Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

67053 1513184208HCLSReviewBulgariaDecember2017.pdf
Energy Boardroom

Czech Republic Pharma Report

October 2016

This report offers companies, investors, policymakers, and stakeholders crucial insight into the Czech Republic; a country transforming itself from merely a producer of cheap generics to the regional headquarters of some of the largest pharmaceutical companies in the world. Located at the beating heart of Europe, boasting a highly-talented yet low-cost workforce, and with a rapidly evolving regulatory framework, the Czech Republic is fast establishing itself as a significant country globally for pharmaceuticals and healthcare.

The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the Czech healthcare and pharma sectors.

want to know more?

contents

  • ACKNOWLEDGEMENTS
  • FOREWORD
  • PREFACE
  • SNAPSHOT IN FIGURES
  • PUBLIC HEALTH REFORM INTERVIEW Svatuplok Němeček, Minister of Health
  • PUBLIC HEALTH POLICY REFORM INTERVIEW Jan Žaloudík, Committee on health and social policy, Czech Republic Senate
  • THE CEE PHARMA SPACE FEATURE Comparative Assessment
  • ICONIC CZECH PHARMA BRANDS INTERVIEW Jean-Marie Arnaud & Soňa Porubská, Sanofi Zentiva
  • BIG PHARMA INTERVIEW Heidrun Irschik, Novartis
  • CZECH ENTREPRENEURSHIP FEATURE Local Innovation Capacity
  • FOREIGN DIRECT INVESTMENT INTERVIEW Karel Kucera, CzechInvest

COVER STORY

GATEWAY TO GREATNESS

  1. To pay, or not to pay?
  2. Turning on the spotlight
  3. At the vanguard of the digital revolution
  4. Dual reference pricing
  5. A flourishing clinical trials segment
  6. Fostering solidarity
  7. Zentiva: a national icon
  8. Lifting the lid on the Czech-Slovak dynamic
  9. Seizing opportunities
  • PUBLIC HEALTHCARE EXPENDITURE FEATURE Enforcing Transparency
  • REIMBURSEMENT INTERVIEW Ladislav Dušek, Institute of Health Information and Statistics
  • EMERGING GROWTH SPOTS FEATURE Women's Health
  • ACQUISITIONS INTERVIEW Rene Bastl, Merck

featuring

  • Svatuplok Němeček Minister of Health
  • Jan Žaloudík Committee on health and social policy, Czech Republic Senate
  • Jean-Marie Arnaud & Soňa Porubská Sanofi Zentiva
  • Heidrun Irschik Novartis
  • Karel Kucera CzechInvest
  • Ladislav Dušek Institute of Health Information and Statistics
  • René Bastl Merck

Most Read


X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: